Toru Kimura Selected Research

xanthofulvin

10/2003

In vitro and in vivo characterization of a novel semaphorin 3A inhibitor, SM-216289 or xanthofulvin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toru Kimura Research Topics

Disease

46	Neoplasms (Cancer) 12/2022 - 05/2005
43	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 03/2008
11	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2008
10	Neoplasm Metastasis (Metastasis) 03/2022 - 12/2006
10	Fibrosis (Cirrhosis) 01/2022 - 02/2011
9	Inflammation (Inflammations) 01/2017 - 10/2003
7	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019 - 05/2004
7	Liver Cirrhosis (Hepatic Cirrhosis) 03/2015 - 04/2008
6	Head and Neck Neoplasms (Head and Neck Cancer) 11/2019 - 04/2009
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 11/2016
4	Retinal Degeneration 01/2022 - 01/2016
4	Acute Lung Injury 01/2018 - 06/2005
4	Liver Diseases (Liver Disease) 09/2014 - 07/2006
4	Infections 04/2012 - 07/2006
3	Proteinuria 01/2022 - 01/2017
3	Hypersensitivity (Allergy) 01/2022 - 10/2005
3	Prostatic Neoplasms (Prostate Cancer) 11/2020 - 05/2016
3	Squamous Cell Carcinoma of Head and Neck 11/2019 - 04/2009
3	Hypertension (High Blood Pressure) 05/2019 - 01/2010
3	Chronic Hepatitis B 01/2017 - 11/2013
3	Chronic Hepatitis C 12/2014 - 03/2012
3	Pneumonia (Pneumonitis) 10/2014 - 05/2004
3	Adenocarcinoma 02/2014 - 06/2012
3	Type 2 Diabetes Mellitus (MODY) 01/2012 - 08/2008
3	Sclerosing Cholangitis 07/2006 - 02/2002
2	Allergic Rhinitis 01/2022 - 11/2018
2	Parkinson Disease (Parkinson's Disease) 10/2021 - 07/2005
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021 - 01/2016
2	Frailty 11/2019 - 11/2018
2	Thrombosis (Thrombus) 05/2019 - 05/2011
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 12/2012
2	Idiopathic Pulmonary Fibrosis 01/2019 - 01/2017
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 11/2008
2	Obesity 01/2017 - 06/2013
2	Agranulocytosis (Granulocytopenia) 01/2017 - 01/2016
2	Cysts 01/2017 - 11/2012
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 01/2015
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2017 - 12/2009
2	Insulin Resistance 01/2017 - 01/2012
2	Carcinogenesis 01/2017 - 09/2016

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 04/2009
9	Sorafenib (BAY 43-9006)FDA Link 08/2017 - 01/2011
8	Proteins (Proteins, Gene)FDA Link 10/2021 - 12/2009
8	Pharmaceutical PreparationsIBA 05/2019 - 08/2008
7	Atrial Natriuretic Factor (ANF)IBA 01/2018 - 04/2010
7	Serum AlbuminIBA 03/2015 - 03/2012
6	Messenger RNA (mRNA)IBA 01/2022 - 10/2009
6	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 01/2017 - 04/2015
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 05/2004
5	CollagenIBA 01/2019 - 11/2012
5	LipopolysaccharidesIBA 01/2018 - 10/2014
5	Branched-Chain Amino AcidsIBA 01/2017 - 03/2012
5	Tumor Biomarkers (Tumor Markers)IBA 01/2015 - 08/2008
4	Fetal Proteins (Fetoprotein)IBA 01/2021 - 08/2013
4	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2017 - 04/2009
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017 - 01/2015
4	Metformin (Glucophage)FDA LinkGeneric 06/2016 - 08/2008
4	Ethiodized Oil (Ethiodol)FDA Link 12/2014 - 09/2012
4	Uric Acid (Urate)IBA 05/2014 - 10/2008
4	Epirubicin (Ellence)FDA LinkGeneric 01/2014 - 05/2011
3	EnzymesIBA 11/2020 - 07/2006
3	Androgen Receptors (Androgen Receptor)IBA 11/2020 - 05/2016
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2017 - 08/2008
3	LigandsIBA 01/2017 - 05/2004
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 10/2009
3	entecavir FDA Link 01/2017 - 11/2013
3	CytokinesIBA 02/2016 - 10/2003
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016 - 02/2011
3	Alanine Transaminase (SGPT)IBA 03/2015 - 01/2015
3	BilirubinIBA 03/2015 - 08/2013
3	InterferonsIBA 12/2014 - 03/2012
3	Semaphorin-3AIBA 12/2006 - 10/2003
3	BezafibrateIBA 07/2006 - 02/2002
2	AllergensIBA 01/2022 - 10/2005
2	Retinaldehyde (Retinal)IBA 01/2021 - 01/2016
2	Amino Acids FDA Link 11/2020 - 05/2016
2	Fluorouracil (Carac)FDA LinkGeneric 11/2019 - 06/2010
2	Antiviral Agents (Antivirals)IBA 01/2019 - 11/2013
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2016
2	Thyroid HormonesIBA 01/2019 - 05/2009
2	Chimeric Antigen ReceptorsIBA 01/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 11/2018 - 08/2017
2	E-SelectinIBA 01/2018 - 03/2015
2	TOR Serine-Threonine KinasesIBA 01/2017 - 06/2016
2	Neutral Amino AcidsIBA 06/2016 - 04/2009

Therapy/Procedure

44	Therapeutics 11/2020 - 12/2006
11	Drug Therapy (Chemotherapy) 01/2018 - 11/2008
5	Transplantation 01/2021 - 07/2005
5	Radiofrequency Ablation 09/2013 - 12/2011
3	Metastasectomy 03/2022 - 09/2017
3	Radiotherapy 07/2021 - 12/2014
3	Aftercare (After-Treatment) 01/2019 - 05/2018
2	Segmental Mastectomy (Lumpectomy) 12/2022 - 04/2010
2	Precision Medicine 01/2022 - 08/2020
2	Length of Stay 07/2021 - 11/2018
2	Castration 11/2020 - 01/2017
2	Cardiac Rehabilitation 11/2019 - 11/2018
2	Immunotherapy 01/2019 - 05/2005
2	Chemoradiotherapy 01/2017 - 11/2016